Telomeres protect chromosome ends through the interaction of telomeric repeats with shelterin, a protein complex that represses DNA damage signaling and DNA repair reactions. The telomeric repeats are maintained by telomerase, which solves the end replication problem. We report that the TTAGGG repeat arrays of mammalian telomeres pose a challenge to the DNA replication machinery, giving rise to replication-dependent defects that resemble those of aphidicolin-induced common fragile sites. Gene deletion experiments showed that efficient duplication of telomeres requires the shelterin component TRF1. Without TRF1, telomeres activate the ATR kinase in S phase and show a fragile-site phenotype in metaphase. Single-molecule analysis of replicating telomeres showed that TRF1 promotes efficient replication of TTAGGG repeats and prevents fork stalling. Two helicases implicated in the removal of G4 DNA structures, BLM and RTEL1, were required to repress the fragile-telomere phenotype. These results identify a second telomere replication problem that is solved by the shelterin component TRF1.
INTRODUCTION
Mammalian chromosome ends feature long arrays of TTAGGG repeats that serve as binding sites for shelterin (de Lange, 2005) , a telomere-specific protein complex that represses the DNA damage response. The stability of mammalian chromosomes and indeed cell viability critically depends on the maintenance of sufficient shelterin binding sites at each telomere. Telomeric DNA can be lost with cell proliferation because of the inability of the DNA replication machinery to duplicate DNA ends. This end replication problem is solved by telomerase, the reverse transcriptase that adds telomeric repeats onto the 3 0 ends of chromosomes (Greider and Blackburn, 1985) , thereby compensating for terminal sequence loss. Most of the long TTAGGG repeat array at the ends of mammalian chromosomes, however, is maintained by semiconservative DNA replication. Our data reveal that telomeric repeats pose a challenge to the DNA replication machinery, giving rise to replication-dependent defects that resemble those of aphidicolin-induced common fragile sites.
Fragile sites represent specific chromosomal regions that challenge replication, especially under conditions of limiting nucleotide pools or partial inhibition of DNA polymerases (Durkin and Glover, 2007) . Examples are the common fragile sites, which are prone to display abnormal features in metaphase chromosomes when cells experience replication stress. Specifically, treatment with low levels of the DNA polymerase inhibitor aphidicolin induces site-specific breaks or gaps in metaphase chromosomes (Glover et al., 1984) . The molecular basis of this replication dependent instability is not known. Common fragile sites are large, and sequence motifs that might explain their behavior have not been identified. The occurrence of breaks or gaps at common fragile sites is enhanced when replication stress is combined with deficiency in the ATR kinase pathway, which responds to stalled replication forks (Casper et al., 2002) . Similarly, inhibition of homology-directed repair, which facilitates replication restart after replication fork collapse, exacerbates the expression of common fragile sites (Arlt et al., 2004) . The idea that common fragile sites represent regions where replication forks stall and collapse is consistent with the increased rate of recombination at these loci (Feichtinger and Schmid, 1989; Glover and Stein, 1987) . Indeed, common fragile sites are hotspots for deletions and other chromosome rearrangements in cancer (Yunis and Soreng, 1984; LeBeau and Rowley, 1984) .
Our data identify telomeres as aphidicolin-induced fragile sites and establish that the shelterin protein TRF1 is required to prevent telomere replication problems. TRF1 is one of the six distinct proteins that make up shelterin (Chong et al., 1995; reviewed in de Lange, 2005) . TRF1 and its paralogs, TRF2, bind to double-stranded TTAGGG repeats of the telomere with high fidelity. Both proteins are abundant at telomeres, binding throughout the telomeric DNA tract. TRF1 and TRF2 interact with TIN2, which also recruits TPP1 and POT1 to chromosome ends. POT1 also binds telomeric DNA, but unlike TRF1 and TRF2, it interacts with the single-stranded TTAGGG repeats in the 3 0 overhang. TRF2 and POT1 contribute to the protection of chromosome ends by repressing DNA damage signaling by the ATM and ATR kinases, respectively (Denchi and de Lange, 2007) . TRF2 and POT1 also repress the two main DNA repair pathways, nonhomologous end joining (NHEJ) and homologydirected repair (HDR) (Celli and de Lange, 2005; Celli et al., 2006; Palm et al., 2009) . Although TRF1 has a similar architecture as TRF2 (Fairall et al., 2001) , it has distinct domains and (A) Schematic of the mouse TRF1 locus on chromosome 1 (NCBI locus ID 21749), the targeting construct, and the altered alleles of TRF1. R, EcoRI; P, PvuII; H, HindIII. F1, F2, and R, PCR primers. (B) TRF1 PCR on tail DNA from mice of the indicated genotypes using the F1 and F2 forward primers and the R reverse primer. PCR products: wild-type, 100 bp; flox, 152 bp; null allele, 500 bp. a different set of interacting partners reviewed in Palm and de Lange, 2008) . TRF1 has been shown to contribute to telomere length regulation (van Steensel and de Lange, 1997; Smogorzewska et al., 2000) , but its role in telomere protection had not been established. Because TRF1 deletion in the mouse is lethal (Iwano et al., 2004; Karlseder et al., 2003) , we generated a conditional allele to examine the role of TRF1 in telomere biology.
RESULTS

Conditional Deletion of TRF1
We generated a conditional allele of the mouse TRF1 gene that allows Cre-mediated deletion of exon 1, which contains the translation start site (TRF1 F ; Figures 1A and 1B) . Introduction of Cre into TRF1 F/F mouse embryo fibroblasts (MEFs) resulted in the expected loss of TRF1 protein within 72 hr ( Figures 1C and 1D ). Consistent with previous reports on the lethality of TRF1 deletion (Iwano et al., 2004; Karlseder et al., 2003) , loss of TRF1 induced a growth arrest and senescence in primary and SV40-LT immortalized MEFs ( Figures 1E and 1F ). As deletion of TRF1 was better tolerated in immortalized MEFs, they were used for these studies unless indicated otherwise. The cell-cycle arrest and other phenotypes of Cre-mediated TRF1 deletion were suppressed by exogenous TRF1 ( Figure S1 available online, and see below), demonstrating that they are indeed a consequence of TRF1 loss. TRF1-deficient cells did not show a strong telomere fusion phenotype, as fewer than 2% of the metaphase chromosomes became joined and genomic DNA analysis showed that both the telomeric restriction fragment lengths and the telomeric 3 0 overhang were unaltered ( Figures S2A and S2B) . These results contrast the phenotype of TRF2 deletion, which induces telomere fusions and a concomitant loss of the 3 0 overhang (Celli and de Lange, 2005) . Deletion of TRF1 also did not lead to the strong increase in telomeric overhang signals observed upon deletion of POT1b, nor did the cells show the endoreduplication phenotype associated with the loss of POT1a (Figures S2B and S2C) (Hockemeyer et al., 2006) . Furthermore, TRF1 deletion did not change the expression levels of Rap1, POT1a, or TRF2 (Figures S2D and S2E and data not shown), and there were only moderate effects on the association of Rap1, TRF2, TPP1, and POT1a with telomeric DNA as measured by ChIP ( Figure S2F ).
TRF1 Deletion Results in Aberrant Telomeres in Metaphase
The most notable phenotype of TRF1 deletion was a high incidence of telomeres with an aberrant structure in metaphase ( Figures 1G and 2A) . The telomeric FISH signal at individual chromatid ends is normally represented as a single signal with an intensity that is roughly equal to the telomeric signal of the sister chromatid end. After TRF1 deletion, a large fraction of chromatids had multiple telomeric signals (Figures 2A and 2B) . In some cases, the multiple signals were spatially separated from the chromatid end, as if the telomeric DNA had failed to condense or was broken. We refer to these various abnormal telomeric patterns as fragile telomeres.
Up to 20% of the telomeres showed this aberrant structure in TRF1 null cells, whereas fragile telomeres were less frequent (<5%) in control cells ( Figure 2B ). Chromosome-orientation FISH (CO-FISH) showed that both sister telomeres were roughly equally prone to display the fragile phenotype ( Figure S3A and data not shown). Aberrant telomeric structures (often referred to as telomere doublets) resembling the fragile telomeres documented here were previously reported in several settings, including embryonic stem cells (ESCs) lacking TRF1 (Philippe et al., 1999; Undarmaa et al., 2004; Iwano et al., 2004; van Overbeek and de Lange, 2006; Blanco et al., 2007; Okamoto et al., 2008) , but the underlying telomeric defect had not been identified.
In addition to the fragile telomeres, we observed frequent associations of sister telomeres in TRF1 null cells ( Figure 2D ). These telomere associations did not result from NHEJ since they also occurred upon deletion of TRF1 from cells lacking DNA ligase IV ( Figure 2D ). The molecular nature of these associations remains to be determined, but, given the data presented below, it is tempting to speculate that the sister telomere associations represent the recently described sister chromatid bridges at fragile sites (Chan et al., 2009 (Glover et al., 1984) , aphidicolin induced breaks in $8% of chromosomes ( Figures  2C, S3B , and S3C). Importantly, aphidicolin induced a striking increase in the frequency of fragile telomeres ( Figure 2B ). The effect of aphidicolin was additive with deletion of TRF1, resulting in $28% of telomeres showing this phenotype ( Figure 2B ). Aphidicolin did not affect the sister telomere associations seen after TRF1 deletion ( Figure 2D ). In order to determine the effect of ATR on the fragile-telomere phenotype, TRF1 F/F MEFs were treated with Cre and subsequently with ATR short hairpin RNA (shRNA) ( Figure S3D ). As for the common fragile sites (Casper et al., 2002) , ATR inhibition strongly enhanced the fragile-telomere phenotype of TRF1-deficient cells . In contrast, inhibition of ATR did not increase the sister telomere association phenotype of TRF1 null cells ( Figure 2D ). Collectively, the data obtained with cells treated with aphidicolin or ATR shRNA demonstrate that telomeres resemble common fragile sites and that this feature of telomeres is partially repressed by TRF1.
S Phase-Dependent ATR Signaling upon Loss of TRF1 Consistent with a DNA replication defect, cells lacking TRF1 showed a strong telomere damage response phenotype, as evidenced by 53BP1 and g-H2AX telomere dysfunction-induced foci (TIFs) ( Figures 3A, 3B , and S4). The TIF response was fully repressed by exogenous TRF1, establishing that it was due to TRF1 loss ( Figure S1 ). Using MEFs with compound genotypes, we determined whether this DNA damage signal depended on the ATM, DNA-PKcs, or ATR kinase. Of these three kinases, only ATR was required for the TIF response ( Figures 3A, 3B , and S5). Consistent with ATR signaling, Chk1 became phosphorylated upon deletion of TRF1, whereas phosphorylation of the ATM target Chk2 was not detected ( Figures 3C and 3D ). We next asked whether progression through S phase was required for the activation of ATR at telomeres lacking TRF1. To test this, we deleted TRF1 from quiescent (G 0 ) primary TRF1 F/À cells. As a positive control, TRF2, which is known to be required for telomere protection in all stages of the cell cycle (Konishi and de Lange, 2008) , was deleted from a parallel culture of quiescent primary TRF2 F/À cells. While deletion of TRF2 resulted in the expected 53BP1 foci at telomeres, the TIF response was minimal in G 0 cells lacking TRF1 ( Figures 3A, 3B , and S5). TIFs only became prominent when the cells were released from G 0 and progressed through S phase ( Figures 3E and S5 ). These results demonstrate that progression through S phase in absence of TRF1 induces an ATR-dependent DNA damage signal at telomeres. As most cells in an asynchronous population of immortalized TRF1 null cells showed numerous TIFs, it is likely that much of the DNA damage generated at telomeres in S phase persists when TRF1 is absent.
Analysis of Telomere Replication in Wild-Type Cells using SMARD We used SMARD (single-molecule analysis of replicated DNA; Norio and Schildkraut [2001] ) to examine the progression of replication forks through telomeric DNA ( Figure 4A ). SMARD relies on two sequential periods of in vivo labeling with different halogenated nucleotides (IdU and CldU) to mark replicating DNA molecules. Genomic DNA from the labeled cells was digested with frequently cutting restriction enzymes that cleave most of the genomic DNA into small fragments but do not cut in the long (>20 kb) TTAGGG repeat arrays, so that DNA fragments with a molecular weight (MW) >25 kb isolated from an agarose gel were enriched for telomeric DNA. The incorporation of IdU and CldU was visualized with fluorescent antibodies in partially denatured DNA molecules stretched onto silanized glass slides. We identified the telomeric DNA fragments with a FISH-PNA probe (TelC) that anneals to the G-rich telomeric repeat strand. Although annealing of the TelC probe interferes with detection of the IdU and CldU in the TTAGGG repeats, substitutions in the CCCTAA repeat strand are detectable. Both the telomeric FISH signal and the IdU or CldU fluorescent signals appeared as strings of dots that were often interrupted due to the partial denaturation of the DNA ( Figure 4A ). Nonetheless, long telomeric DNA molecules were readily identified among the mixture of DNA fragments. The optimized procedure used pulse-labeling periods of 30 min followed by a 3 hr chase. Since this procedure only labels the DNA in cells that are in S phase during the pulses, the protocol was further improved by repeating the pulse-chase six times. The total duration of the six rounds of pulse/chase was 21 hr, which is less than the cell doubling time. As replication forks progress at $2 kb/min (Anglana et al., 2003) , even the longest telomeres ($150 kb) should be fully replicated within one round of the double-pulse/chase procedure. As expected, the average length of the IdU and CldU segments was approximately equal, and the two substitutions were observed in approximately equal fractions of the telomeric DNA molecules. Because the telomeric DNA fragments used for the analysis are of variable lengths, the rate of fork progression cannot be determined accurately in these experiments. However, given that we frequently observed telomeric fragments in the >25 kb size range that were completely labeled with either IdU or CldU in experiments using 30 min pulses, it is unlikely that the fork rate is lower than 1 kb/min.
The final protocol yielded telomeric DNA molecules with a pattern of IdU/CldU incorporation that could be consistent with replication proceeding from a subtelomeric origin toward the chromosome end ( Figure 4A ). To determine the direction of the replication fork, we analyzed telomeric DNA molecules with an attached segment of subtelomeric DNA generated by digestion with SwaI ( Figure 4B ). The length of the telomeric SwaI fragments is $180 kb as identified by genomic blotting (see inset in Figure 4B ). In this size fraction of SwaI-digested DNA, the telomeric fragments are not strongly enriched, limiting the number of telomeric molecules available for analysis. Nonetheless, we identified 90 telomeric SwaI restriction fragments, which had a labeled (IdU or CldU) segment that extended beyond the telomeric DNA labeled with FISH ( Figure 4B ). The presence of IdU or CldU in the subtelomeric segment and the absence of substitution in the distal end of the molecules is consistent with progression of the replication fork from a subtelomeric site into the telomeric DNA. We also observed molecules with IdU in the normal medium on day 3 after Cre and harvested 15 hr after release. S/G2 cells were released into normal medium followed by an aphidicolin block and analyzed 7 hr after release from the G1/S block. Bar graphs represent mean values of three independent experiments and SDs. TRF1 was deleted in $50% of the cells ( Figure S5 ). FACS analysis of the G 0 , G1, and S/G2 cells is shown in Figure S5 .
subtelomeric segment that contained IdU at the proximal end and CldU at the distal end. Again, this configuration is consistent with replication from a subtelomeric origin.
Occasional Replication Initiation within Telomeric Repeats in Wild-Type Cells
We observed a small number of telomeric DNAs that suggested initiation of DNA replication within the telomeric repeats ( Figure 4C ). These molecules contained an IdU segment flanked on both sides by segments of CldU, indicating that replication had started in the telomeric sequences during the IdU pulse and continued in both directions during the CldU pulse. In some cases, replication proceeded both from a subtelomeric origin and an origin within the telomere, leading to convergence of two forks within the telomeric repeats. The frequency of initiation events within the telomeric DNA was low; only $3% of telomeric molecules showed a pattern consistent this mode of replication. Occasional initiation of DNA replication in the telomeric repeat array is consistent with the relative lack of sequence specificity of mammalian ORC (Falaschi et al., 2007) . In addition, the association of ORC components with shelterin (Deng et al., 2007; Tatsumi et al., 2008; Atanasiu et al., 2006) could contribute to formation of a prereplication complex within the telomeric DNA.
Diminished Telomeric Replication upon Deletion of TRF1
To determine whether TRF1 affected the efficiency of telomere replication, we measured the fraction of telomeric DNA molecules that contained either IdU or CldU (or both) in DNA obtained from TRF1-proficient and -deficient cells ( Figure 5 ). In three independent experiments, the deletion of TRF1 resulted in an $2-fold lower incorporation of halogenated nucleotides in telomeric DNA molecules regardless of their length. This effect was not due to a general reduction in DNA replication since the incorporation of BrdU was not altered at the time point studied ( Figure S2C ). As a control, the well-studied replicating region derived from the Igh locus (Norio et al., 2005) was unaffected by deletion of TRF1 ( Figure 5 ). Thus, deletion of TRF1 had a specific effect on the replication of telomeric DNA. Furthermore, the efficiency of telomere replication was not altered when TRF2 was deleted from TRF2 F/À Lig4 À/À MEFs ( Figure 5 ), and deletion of TRF2 did not induce a fragile-telomere phenotype (Celli and de Lange, 2005) , indicating a specific role for TRF1 in facilitating telomere replication.
Evidence for Replication Fork Stalling
Inspection of SwaI-digested telomeric DNA molecules, which carry a subtelomeric DNA segment, revealed several cases of IdU/CldU-labeling patterns consistent with replication fork stalling in or before the telomeric DNA ( Figure 6A ). Among 97 telomeric molecules from TRF1-deficient cells, seven showed IdU or CldU incorporation in the subtelomeric DNA but no incorporation in the telomeric segment. These patterns would indicate that in the absence of TRF1, the fork has a greater tendency to stall when it encounters telomeric DNA. Such molecules were not identified among 78 telomeric SwaI fragments that were derived in a parallel experiment with TRF1-proficient cells.
Additional evidence for fork stalling was obtained from the occasional molecules generated by replication initiation within the telomeric repeats. We observed telomeric DNA molecules with a nonterminal IdU segment that was short compared to other molecules in the same experiment, indicative of initiation of replication in the telomeric DNA at the end of the IdU pulse ( Figure 6B ). In these molecules, the IdU segment is flanked on one side by CldU, indicating fork progression during the CldU-labeling period. Importantly, a significant number of these molecules showed no CldU incorporation at the other side of the IdU segment, indicating that the fork on that side did not progress during the CldU-labeling period. Although the number of this type of replication products was small (14 out of 250 IdU-and/or CldU-labeled molecules), they were never observed in DNA from TRF1-proficient cells processed in parallel (400 IdU-and/or CldU-labeled molecules examined), demonstrating again that absence of TRF1 impairs the normal progression of the replication fork.
Fragile Telomeres in Human Cells
We next asked whether human telomeres also resemble fragile sites. Since it is difficult to fully inactivate human TRF1 with RNA interference (RNAi) or dominant-negative alleles, we determined whether treatment of human cells with aphidicolin induced the fragile-telomere phenotype. Using the same low level of aphidicolin applied to mouse cells, we observed an increase in the frequency of fragile telomeres as compared to untreated cells ( Figure S7A ). Thus, it is likely that human and mouse telomeres are similar with regard to posing a challenge to the replication fork.
Effect on Telomere Maintenance
We considered the possibility that the fragile-telomere phenotype might lead to loss of telomeric DNA. TRF1 null cells contained a small fraction of chromosome ends that appeared to lack telomeric signals, and this phenotype was somewhat stronger when ATR was inhibited ( Figure S2A ). However, the length of the telomeric restriction fragments of TRF1 null cells was unaltered ( Figure S2B ). Because small telomere length changes are difficult to detect in mouse cells, we addressed the question of potential telomeric DNA loss in the human fibrosarcoma clone HTC75. We followed the effect of aphidicolin on telomere length in HTC75 cells over 50 population doublings ( Figure S7C ). As a control, parallel cultures were treated with a concentration of zeocin that induced approximately the same number of DNA damage foci per cell ( Figure S7D ). Neither zeocin nor aphidicolin induced loss of the telomeric DNA in HTC75 cells. Rather, aphidicolin, but not zeocin, resulted in moderate telomere elongation ( Figure S7B) . Thus, the replication problems in telomeres are not a major source of telomere loss in telomerase-positive cells, and they may even enhance the telomerase pathway. In budding yeast, partial inhibition of DNA replication also induces telomere elongation (Carson and Hartwell, 1985; Adams and Holm, 1996) .
The Mechanism by which TRF1 Represses Telomere Fragility As deletion of TRF1 but not TRF2 affected telomere replication, we asked whether a specific feature of TRF1 was responsible for A C B its function. Although TRF1 is notably different from TRF2 in its N-terminal domain, which is acidic, this domain was not responsible for the repression of replication problems. TRF1
DAc fully repressed the fragile-telomere phenotype of TRF1 null cells, whereas TRF1 DMyb , which lacks the ability to bind to telomeric DNA, was unable to complement the loss of the endogenous TRF1 ( Figures 7A and 7B ). The repression of replication problems was also not due to a change in TERRA, a class of RNA polymerase II transcripts that contain UUAGGG repeats (Azzalin et al., 2007) . Although TRF1 was shown to be in a complex with RNA polymerase II, and was suggested to contribute to TERRA metabolism (Schoeftner and Blasco, 2008) , no change in the abundance of TERRA was observed in TRF1 null cells ( Figure 7B ).
We next considered that TRF1 might repress replication problems by recruiting a class of helicases that can remove G4 DNA , DNA was digested with frequently cutting enzymes, and telomeric restriction fragments >25 kb were isolated (schematic on the left). Telomeric DNA molecules were identified by FISH, and the percent of molecules containing IdU and/or CldU was determined. In the middle panel, telomeric MboI/AluI fragments in the 130-180 kb range (see genomic blot inset) were isolated from a CHEF gel, and the fraction of telomeric molecules that contained IdU and/or CldU was determined as above. SMARD assay was done in one experiment in which TRF2 was deleted from TRF2 F/F DNA-Lig4 À/À cells and the fraction IdU-and/or CldU-labeled telomeric molecules (130-180 kb range) was analyzed. In the lower panel, the DNA preparation of TRF1 F/F MEFs used in the middle panel was digested with SwaI and a 180 kb restriction fragment from the Igh locus was isolated. DNA probes from that locus (see map below) were used to identify the Igh fragments on stretched DNA, and the ratio of labeled versus unlabeled fragments was determined. structures. G4 DNA can be formed by single-stranded TTAGGG repeats and might impede the replication fork. One candidate helicase is the BLM RecQ helicase, which contains the FxLxP TRF1 binding motif (FILMP at aa 311 of human BLM), binds TRF1 in vitro (Lillard-Wetherell et al., 2004) , and binds and unwinds G4 DNA (Sun et al., 1998; Huber et al., 2002; Huber et al., 2006) . Indeed, BLM-deficient mouse cells (Luo et al., 2000) showed a high frequency of spontaneous fragile telomeres ( Figure 7C ), whereas cells lacking another RecQ helicase, WRN, did not show this phenotype. Furthermore, a BLM shRNA induced the fragile-telomere phenotype, and this effect appeared to be epistatic with TRF1 ( Figures 7D and 7E) . A second candidate helicase that has been proposed to act on G-rich telomeric DNA is RTEL1, which affects telomere length setting in mouse species (Ding et al., 2004) and was recently shown to be functionally similar to Srs2, a budding yeast helicase that inhibit the Rad51 HDR pathway (Barber et al., 2008) . Interestingly, the published metaphases of RTEL1-deficient ESCs show a mild fragile-telomere phenotype, although the frequency of this phenotype was not reported (Ding et al., 2004 Figure 5 , top panel. The patterns of incorporation of IdU and CldU are consistent with initiation of replication within the telomeric DNA near the end of an IdU pulse followed by fork progression in only one direction during the CldU-labeling period.
shRNA induced fragile telomeres, and, as was the case with BLM, this phenotype appeared epistatic with deletion of TRF1 ( Figures 7D and 7E ). It will be necessary to derive Blm/TRF1 DKO and Rtel1/ TRF1 DKO cells to further corroborate that TRF1 acts by recruiting/activating these helicases to telomeres.
DISCUSSION
Mammals employ TTAGGG repeats to mark the ends of their chromosomes. These repeats have been used to protect chromosome ends throughout eukaryotic evolution and remain the predominant telomeric repeat in most eukaryotic phyla. Despite the obvious utility of this sequence, there is a potential drawback of the TTAGGG repeat-based telomere protection strategy, which we report on here. Our data establish that the telomeric regions of mouse and human chromosomes challenge DNA replication, leading to a phenotype resembling common fragile sites.
Telomeres as Fragile Sites
Telomeres were not previously recognized as fragile sites, most likely because their terminal position prohibits the observation of the DNA distal to the gaps and breaks, unless the telomeric DNA is highlighted by FISH. Telomeric FISH showed that telomeres can attain a variety of aberrant structures, ranging from a simple gap to long strings of fragmented telomeric signals or even an extended strand of telomeric DNA. These cytological aspects of the fragile-telomere phenotype are informative because they provide direct observation of the aberrant structure. In contrast, FISH probes that mark the center of instability of the very large common fragile sites often do not coincide with the actual breaks or gaps, which can occur at a distance (Becker et al., 2002) .
Since the structure of the fragile telomeres is highly varied, it is unlikely that the underlying lesion is a simple double-stranded DNA break. Our observations are more compatible with altered packaging and/or condensation of the chromatin perhaps due to extended areas of single-stranded DNA resulting from incomplete replication or processing of stalled forks.
The Origin of the Telomere Replication Problem It will be important to determine what aspect of the telomeric DNA is causing problems during DNA replication. The fragiletelomere phenotype is not a consequence of late replication as mammalian telomeres replicate throughout S phase (Ten Hagen et al., 1990; Wright et al., 1999) . We also consider it unlikely that the terminal position of the TTAGGG repeats is responsible for the fragile nature. First, it is clear from our data that fork arrest is occurring at a substantial distance from the actual chromosome end. Furthermore, an aphidicolin-induced fragile site in Chinese hamster chromosomes is at or near interstitial telomeric DNA (Musio et al., 1996) , suggesting that internally placed telomeric repeats can cause the same problems as terminal ones. Similarly, TTAGGG repeats induce chromosome rearrangements when introduced at an internal locus (Kilburn et al., 2001 ). The problems caused by chromosome-internal TTAGGG repeats also argue against the idea that the t loop structure plays a role in the replication defects.
Another possibility is that the telomeric DNA itself does not impair replication but becomes a challenge when bound to the telomeric protein complex. For instance, the single-stranded telomeric DNA binding protein POT1 may compete with RPA, thereby hampering lagging strand DNA synthesis. However, TTAGGG repeats also impair DNA replication in budding yeast (R. Wellinger, personal communication). Since budding yeast lacks shelterin, this result argues that TTAGGG repeats provide an inherent problem to the replication fork, regardless of the proteins bound or the presence of t loops.
We favor the view that the telomeric DNA is a problematic substrate for the replication machinery, most likely due to formation of G-G Hoogsteen base-paired G4 DNA in the G-rich telomeric repeat strand. Our finding that BLM and RTEL1, two helicases that have been implicated in the removal of G4 DNA, repress the fragile-telomere phenotype is consistent with the idea that the fork is primarily hindered by secondary structures formed by the G-rich telomeric DNA. If correct, this would predict that G4 ligands such as telomestatin and RHPS4 might induce a fragile-telomere phenotype and that some of their effects on the growth of tumor cells (Salvati et al., 2007; Tahara et al., 2006; Gomez et al., 2006) may be due to their preferential inhibition of telomere replication.
The Function of TRF1
Within shelterin, TRF2 and POT1 proteins collaborate to repress all DNA damage response pathways that threaten chromosome ends: DNA damage signaling by the ATM and ATR kinases and NHEJ-and HDR-mediated DSB repair. These functions are needed throughout the cell cycle, and loss of TRF2 or POT1 proteins in G0, G1, S, or G2 result in a DNA damage response (Celli and de Lange, 2005; Hockemeyer et al., 2006; Konishi and de Lange, 2008) 
TRF1 has a specific function in S phase, facilitating the replication of telomeres, thereby preventing ATR activation and the formation of fragile telomeres in metaphase.
Our data suggest that TRF1 primarily acts through the recruitment of BLM and RTEL1, but other factors are not excluded. Neither RTEL1 nor BLM were observed in an exhaustive PIChbased analysis of proteins associated with HeLa cell telomeres, although BLM was found at ALT telomeres (Dejardin and Kingston, 2009 ). However, it is possible that the association of these helicases is transient and therefore escapes detection.
Deletion of the presumed fission yeast ortholog of TRF1 and TRF2, Taz1, results in a block in telomere replication (Miller et al., 2006) . When Taz1 is absent, 2D gels reveal an aberrant class telomeric fragments, referred to as the ''plume,'' speculated to represent replication problems. Deletion of Taz1 also resulted in fork stalling at a chromosome-internal segment of telomeric DNA. Furthermore, the telomeres of taz1 À cells are rapidly lost and require constant resynthesis by telomerase. These findings are consistent with a role for Taz1 in promoting replication through telomeric DNA and further underscore the similarity of fission yeast and mammalian telomeres (see also Miyoshi et al., 2008) .
Implications
The finding that mammalian telomeres resemble fragile sites makes several predictions. Common fragile sites are prone to sister chromatid exchanges, often undergo rearrangements, and are frequent targets of integration of exogenous DNA (reviewed in Durkin and Glover, 2007) . With regard to the first hallmark of common fragile sites, the fragile telomeres in TRF1 null cells do not appear to undergo frequent telomere sister chromatid exchanges (T-SCEs; Figure S2 ). However, T-SCEs are known to be repressed by TRF2 and POT1a/b, which remain associated with telomeres in TRF1 null cells (Celli et al., 2006; Palm et al., 2009) . With regard to the second hallmark of common fragile sites, their propensity to undergo rearrangements, recent work on focal deletions in colon carcinomas has been revealing. A large fraction (16%) of focal deletions occur near telomeres (Scott Powers, personal communication), consistent with genome rearrangements due to the fragile nature of telomeres and providing a parallel with the tumor-like microdeletions at common fragile sites (Arlt et al., 2009; Durkin et al., 2008) . In addition, human chromosome ends show frequent duplications in subtelomeric sequences, and the rate of sister chromatid exchange is high near the telomeres (reviewed by Riethman, 2008) . Both phenomena may be related to the fragile-telomere phenotype described here.
Finally, with regard to the integration of foreign DNA into common fragile sites, it is noteworthy that chromosome ends are often enriched for mobile elements. For instance, a human herpes virus (HHV-6) was recently show to preferentially integrate in telomeres (P.G. Medveczky, personal communication), and LINE-1 elements can transpose to telomeres in certain hamster cell lines (Morrish et al., 2007 ). An extreme version of telomere-tropic integration is found in the bdelloid rotifers, which have chromosome ends littered with foreign DNA, including mobile elements and DNA derived from horizontal gene transfer Figure S6 for validation of the shRNAs. (Gladyshev et al., 2008) . Although the preferred telomeric invasion in the bdelloid rotifers and mammalian cells could be due to addition of DNA to the termini of deprotected telomeres followed by telomere healing by telomerase, it is also possible that integration is biased by frequent replication fork arrest within the telomeric repeat array. In the latter scenario, the invading element is less likely to compromise telomere function. One could speculate that frequent fork arrest in subtelomeric/telomeric regions could have adaptive value since it would provide a safe sink for mobile elements that might otherwise invade more precious parts of the genome. This could explain why throughout eukaryotic evolution, telomeres have not evolved away from the TTAGGG repeats that generate replication problems. , and DNA-PKcs À/À mice (Barlow et al., 1996; Brown and Baltimore, 2003; Gao et al., 1998) . MEFs were isolated from E13.5 embryos and immortalized with pBabeSV40-LT (a gift from Greg Hannon). SV40-LT-immortalized Wrn
, and Wrn À/À Blm À/À mouse ear fibroblasts were a gift from Brad Johnson. Cre recombinase was introduced with Hit&Run-Cre, Ad5 CMV Cre, or pWZL-Cre as described previously (Celli and de Lange, 2005) . Aphidicolin treatments (0.2 mM) were for 16 hr. shRNAs for Blm (shBLM3c; GGACCTG CTGGAAGATTTA) and ATR (shATR3-1; Denchi and de Lange [2007] ) were introduced using four infections at 6 hr intervals with pSuperior puromycin retrovirus. shRNA for Rtel1 (pLK0.1 from Open Biosystems) was introduced using two lentiviral infections at 12 hr intervals.
Analysis of Telomeric DNA, IF, IF-FISH, Immunoblotting, FACS, and SA-b-Gal Assays
Telomeric overhang signals and telomeric restriction fragment patterns were determined by in-gel analysis as previously described (Celli and de Lange, 2005) . FISH for telomeric DNA was performed with a C-strand PNA probe on methanol/acetic acid-fixed metaphase spreads as previously described (Dimitrova et al., 2008) . For IF-FISH and immunoblotting, previously described standard methods were used (Celli and de Lange, 2005; Dimitrova et al., 2008) . For FACS analysis, cells were plated at 1 3 10 6 cells and harvested 24 hr later.
Ten micromolar BrdU was added to the media 1 hr prior to harvesting. Fixation was done with ice-cold 70% ethanol at 4 C for >30 min. Cells were washed twice with 0.5% BSA in PBS and resuspended in 0.4 ml 0.5% BSA in PBS containing 5 mg propidium-iodide and RNaseA (100 mg/ml). Samples were analyzed with a FACScalibur flow cytometer (Becton Dickinson) with FlowJo software. SA-b-GAL staining was preformed for 8-16 hr at 37 C as previously described (Dimri et al., 1995) .
SMARD Assay
The SMARD assay was performed essentially as described previously (Norio and Schildkraut, 2001) . Cells were sequentially labeled with 25 mM IdU (30 min or 1 hr) and 25 mM CldU (30 min or 1 hr) with three PBS washes in between followed by incubation with media without IdU/CldU for 3 hr. This process was repeated six times for 30 min pulses and three times for 1 hr pulses. DNA isolation and processing for SMARD were as described previously (Norio and Schildkraut, 2001) . DNA was stretched on microscope slides coated with 3-aminopropyltriethoxysilane (Sigma). After stretching, the DNA was denatured in alkali-denaturing buffer (0.1 N NaOH in 70% ethanol and 0.1% b-mercaptothanoland) for 8, 12, or 15 min and fixed by addition of 0.5% glutaraldehyde for 5 min. Telomeric DNA was identified by hybridization with a Biotin-OO-(CCCTAA)4 PNA probe and Alexa Fluor 350-conjugated NeutrAvidin antibody (Molecular Probes) followed by biotinylated anti-avidin antibody (Vector). Halogenated nucleotides were detected with a mouse anti-IdU monoclonal antibody (Becton Dickinson) and a rat anti-CldU monoclonal antibody (Accurate). Alexa Fluor 568-conjugated goat anti-mouse (Molecular Probes) and Alexa Fluor 488-conjugated goat anti-rat were used as secondary antibodies (Molecular Probes).
Telomeric ChIP Analysis IP of telomeric chromatin was performed as previously described (Loayza and de Lange, 2003) and analyzed by dot-blotting using a TTAGGG repeat probe and a BamHI repeat probe as a negative control. Input DNA was used to calculate the % telomeric DNA brought down in the ChIPs. The following antibodies were used as crude sera: TRF1, 1449 (rabbit polyclonal); TRF2, 1254 (rabbit polyclonal); Rap1, 1252 (rabbit polyclonal); POT1a, 1220 (rabbit polyclonal); and TPP1, 1150 (rabbit polyclonal).
TERRA Analysis
Total cellular RNA was prepared with the RNeasy Mini Kit (QIAGEN), according to the manufacturer's instructions, and northern blot analysis was performed as previously described (Azzalin et al., 2007) . Blots were prehybridized at 60 C for 1 hr in Church mix (0.5 M Na 2 HPO 4 [pH 7.2], 1 mM EDTA, 7% SDS, and 1% BSA), followed by hybridization at 60 C overnight with 800 bp telomeric DNA probe from pSP73Sty11 labeled with a C-strand primer, Klenow polymerase, and a-[ 32 P]-dCTP. The blot was exposed to a PhosphorImager screen and scanned with Image-Quant software.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and seven figures and can be found with this article online at http://www.cell. com/supplemental/S0092-8674(09)00721-1.
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